Vident Investment Advisory’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,681
| Closed | -$38.4K | – | 1316 |
|
|
2022
Q4 | $38.4K | Hold |
16,681
| – | – | ﹤0.01% | 1160 |
|
|
2022
Q3 | $54K | Sell |
16,681
-3,280
| -16% | -$10.6K | ﹤0.01% | 1095 |
|
|
2022
Q2 | $110K | Hold |
19,961
| – | – | ﹤0.01% | 1187 |
|
|
2022
Q1 | $47K | Buy |
19,961
+7,331
| +58% | +$17.3K | ﹤0.01% | 1249 |
|
|
2021
Q4 | $76K | Sell |
12,630
-3,838
| -23% | -$23.1K | ﹤0.01% | 1193 |
|
|
2021
Q3 | $228K | Buy |
+16,468
| New | +$228K | 0.01% | 1061 |
|